Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-EN
Language English English
Date Updated 2020-06-04 2020-05-29
Drug Identification Number 02243595 02243595
Brand name ASMANEX TWISTHALER ASMANEX TWISTHALER
Common or Proper name mometasone furoate dry powder inhaler mometasone furoate dry powder inhaler
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients MOMETASONE FUROATE MOMETASONE FUROATE
Strength(s) 200MCG 200MCG
Dosage form(s) POWDER POWDER
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 60dose 60dose
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-06-03 2020-06-01
Actual start date 2020-06-03
Estimated end date 2020-06-12 2020-06-12
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments